Your browser doesn't support javascript.
loading
Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophrenia.
Saleh, Y; Jarratt-Barnham, I; Petitet, P; Fernandez-Egea, E; Manohar, S G; Husain, M.
Afiliação
  • Saleh Y; Nuffield Department Clinical Neurosciences, University of Oxford, Level 6, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, UK. youssuf.saleh@ndcn.ox.ac.uk.
  • Jarratt-Barnham I; Department of Psychiatry, University of Cambridge, Herchel Smith Building for Brain & Mind Sciences, Forvie Site, Robinson Way, Cambridge, CB2 0SZ, UK.
  • Petitet P; Cambridge Psychosis Centre, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
  • Fernandez-Egea E; Nuffield Department Clinical Neurosciences, University of Oxford, Level 6, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
  • Manohar SG; Centre de Recherche en Neurosciences de Lyon, Equipe Trajectories, Inserm UMR-S 1028, CNRS UMR 5292, Universite Lyon 1, Bron, France.
  • Husain M; Department of Psychiatry, University of Cambridge, Herchel Smith Building for Brain & Mind Sciences, Forvie Site, Robinson Way, Cambridge, CB2 0SZ, UK.
Mol Psychiatry ; 28(11): 4831-4841, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37626135

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Clozapina / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Clozapina / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article